July 29, 2025

Alcon Announces US Launch of Tryptyr for DED

Tryptyr (acoltremon ophthalmic solution) 0.003% is now available to prescribe to patients.

Ophthalmology Management

May 01, 2025

Dry Eye Best Practices Must Surpass Standards of Care

In many ways, we are living in a golden age when it comes to all things dry eye. Indeed, there are few areas in medicine with more active research. Many millions of dollars have been invested in the search for better ways to treat dry eye disease (DED).

Ophthalmology Management

April 01, 2025

Cataract Surgery in Patients With Corneal Disease

In the “Cataract Surgery in Patients with Corneal Disease” session at the 2025 ASCRS meeting, Zeba A. Syed, MD, provided an overview of several corneal diseases and what physicians need to know when it comes to treating cataract patients.

Ophthalmology Management

March 01, 2025

Prescribing for Presbyopia

Discover tips for fitting translating GP multifocal contact lenses and maximizing visual performance in this insightful article by Nicholas Gidosh, OD.

Contact Lens Spectrum

May 01, 2025

What Are the Options Now?

The onset of presbyopia can pose a challenge to practitioners when attempting to satisfy the visual needs of contact lens wearers, particularly those who require astigmatic correction as well.

Contact Lens Spectrum

July 01, 2024

GUEST EDITORIAL: My Corneal Playlist

The process of curating content for this issue of Corneal Physician was the same process I use to select songs. Only instead of asking myself, “what songs should be on this playlist,” (David Guetta’s “Titanium” is a must track for a any club, by the way), I asked myself, “What topics should be in this issue?” What follows is my corneal playlist, each accompanied by fantastic artists.

Corneal Physician

January 01, 2024

CLINICAL: Dry Eye: A welcomed reminder

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

May 21, 2025

Small Drop, Big Impact

Could Miebo represent a genuine innovation for ocular surface disease (OSD) treatment and management?

The Ophthalmologist

May 08, 2025

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap

In a dry eye chamber trial, Reproxalap was statistically superior (P = .002) to vehicle in primary endpoint of ocular discomfort.

Ophthalmology Management